More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$13.62B
EPS
-2.09
P/E ratio
--
Price to sales
1.19
Dividend yield
0.152%
Beta
0.597558
Previous close
$26.41
Today's open
$26.51
Day's range
$26.09 - $26.67
52 week range
$15.73 - $30
show more
CEO
Andrew P. Hider
Employees
37500
Headquarters
Deerfield, IL
Exchange
New York Stock Exchange
Shares outstanding
516995999
Issue type
Common Stock
Healthcare
Medical Equipment & Supplies
Baxter Appoints John Rogers Chief Financial Officer
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced it has appointed John Rogers as executive vice president and chief financial officer (CFO), reporting to Baxter president and chief executive officer (CEO), Andrew Hider, effective Oct. 1, 2026. “John is a proven global finance executive with extensive operational expertise and a successful track record leading complex transformation initiatives,” said Hider. “He is an ideal fit for.
Business Wire • Aug 19, 2026

Baxter Announces Early Tender Results and Upsizing of Previously Announced Cash Tender Offers
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX) (“Baxter” or the “Company”) today announced the early results of its previously announced cash tender offers (each, an “Offer” and collectively, the “Offers”) for its validly tendered (and not validly withdrawn) notes set forth below (collectively, the “Notes”). The Offers are being made pursuant to an Offer to Purchase, dated Aug. 4, 2026 (as it may be amended or supplemented from time to time, the “Offer to Purchase”), whi.
Business Wire • Aug 18, 2026

Baxter Announces Pricing for Its Upsized Cash Tender Offers
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX) (“Baxter” or the “Company”) today announced the pricing terms for its previously announced cash tender offers (each, an “Offer” and collectively, the “Offers”) of the Company's validly tendered (and not validly withdrawn) notes set forth below (the “Notes”) using a “waterfall” methodology under which the Company will accept the Notes in order of their respective acceptance priority levels noted in the table below (the “Accep.
Business Wire • Aug 18, 2026

Baxter Announces Cash Tender Offers
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX) (“Baxter” or the “Company”) today announced that it has commenced cash tender offers (each, an “Offer” and collectively, the “Offers”) for the maximum principal amount of validly tendered (and not validly withdrawn) notes set forth below (collectively, the “Notes”), such that the aggregate purchase price, not including accrued and unpaid interest, payable in respect of such Notes will not exceed $500 million. The terms and c.
Business Wire • Aug 4, 2026

Baxter International: The Gains Can Continue, But Should Slow
Baxter International has shown early signs of a turnaround, with improving execution and raised revenue guidance supporting cautious optimism. BAX's valuation has expanded from distressed levels, now trading at ~13x earnings and ~9.5x EV/EBITDA, yet remains attractive if growth continues. Management's focus on operational improvements, cost savings, and a conservative outlook suggests potential for further upside if EPS growth materializes.
Seeking Alpha • Aug 3, 2026

Why Baxter International Stock Skyrocketed by 19% This Week
It scored double beats on analyst estimates. It also lifted its guidance on both the top and bottom lines.
The Motley Fool • Aug 1, 2026

Baxter raises annual profit forecast on strong demand for IV solutions
Medical products maker Baxter International on Thursday raised its annual profit forecast and beat Wall Street estimates for quarterly results, banking on robust sales of its medical products such as IV solutions.
Reuters • Jul 30, 2026

Baxter Jumps After Q2 Beat, Boosted 2026 Guidance Reflects Turnaround Progress
Baxter International Inc. (NYSE:BAX) stock is trading higher on Thursday after the company reported better-than-expected second-quarter financial results and raised its fiscal 2026 guidance.
Benzinga • Jul 30, 2026

Baxter International Inc. (BAX) Q2 2026 Earnings Call Transcript
Baxter International Inc. (BAX) Q2 2026 Earnings Call Transcript
Seeking Alpha • Jul 30, 2026

Baxter Reports Second-Quarter 2026 Results
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the second quarter of 2026. “Our second-quarter results exceeded expectations on both the top and bottom lines, driven by both operating performance and an additional benefit from a tariff refund that was not previously contemplated in our guidance,” said Andrew Hider, president and CEO. “While we're encouraged by this steady progress and core operating momentum, we remain.
Business Wire • Jul 30, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Baxter International Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.